Log In
Print this Print this

Hexokinase 2 inhibitor

  Manage Alerts
Collapse Summary General Information
Company vTv Therapeutics Inc.
DescriptionHexokinase 2 (HK2) inhibitor
Molecular Target Hexokinase 2 (HK2)
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard Indication Cancer (unspecified)
Indication DetailsTreat cancer
Regulatory Designation
PartnerCalithera Biosciences Inc.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today